Envision's shares rose 2.5 percent to $44.76, their highest in almost eight months. However, with the company undergoing a challenging period, it may be a relatively good result for investors who towards the start of November 2017 owned shares in the company which were valued at $24 by the stock market. The company has a quick ratio of 2.25, a current ratio of 2.27 and a debt-to-equity ratio of 0.65.
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Envision Healthcare Corporation ("Envision Healthcare" or "the Company") (NYSE: EVHC News) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the sale of the Company to KKR & Co. The stock of Envision Healthcare Corporation (NYSE:EVHC) earned "Buy" rating by Canaccord Genuity on Tuesday, March 13. The firm also took WebMD Health Corp WBMD.O private for about $2.8 billion.More news: Steam finally adds voice chat and flexible friend lists in new beta
A number of research firms have issued reports on EVHC. ProShare Advisors LLC boosted its stake in shares of Envision Healthcare by 1.7% in the first quarter. The company reported $0.69 earnings per share for the quarter, hitting the Thomson Reuters' consensus estimate of $0.69.
The deal marks an end to Envision's plan to find strategic options, which the company launched after posting disappointing third-quarter results previous year. OLD Mutual Customised Solutions Proprietary Ltd. increased its position in shares of Envision Healthcare by 88.2% during the fourth quarter. Two equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and eight have assigned a buy rating to the company. The firm earned "Hold" rating on Friday, January 5 by Cantor Fitzgerald. Envision Healthcare now has a consensus rating of "Hold" and an average price target of $41.10. Fox Run Management L.L.C. bought a new stake in shares of Envision Healthcare during the 4th quarter worth $353,000. The company's revenue was up 10.6% compared to the same quarter last year. sell-side analysts forecast that Envision Healthcare will post 3.39 earnings per share for the current year. Cantor Fitzgerald maintained it with "Hold" rating and $4000 target in Monday, May 7 report.More news: Tickets still available for World Cup, including England opener
Envision Healthcare Corporation (NYSE:EVHC) has declined 22.24% since June 12, 2017 and is downtrending. The Company's physician-led services encompass providers at approximately 1,500 clinical departments at healthcare facilities in 45 states and the District of Columbia that include emergency department and hospitalist, anesthesiology, radiology/tele-radiology, and children's services. The firm operates through three reportable divisions: Physician Services, Medical Transportation, and Ambulatory Services.